Literature DB >> 29665996

Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.

Young-Eun Kim1, Ki-Wook Oh2, Min-Young Noh2, Jinseok Park2, Hee-Jung Kim3, Jong Eun Park4, Chang-Seok Ki5, Seung Hyun Kim6.   

Abstract

ATXN2 intermediate-length trinucleotide repeat expansions have been reported as a risk factor for amyotrophic lateral sclerosis (ALS) in various ethnicities. We tried to confirm this finding in Korean patients with ALS by screening ATXN2 cytosine-adenine-guanine nucleotide sequences (CAG) repeat lengths in 464 unrelated ALS patients and 703 controls. The most common and the highest CAG repeat lengths in the controls were 22 and 28, respectively, whereas those in ALS patients were 22 and 33, respectively. The frequency of CAG repeat lengths of 30 or more was significantly different between the 2 groups after Bonferroni correction (1.5% in ALS vs. 0% in controls, corrected p = 0.0075). There were no significant differences in gender, age at onset, site of onset, functional rating scale-revised score at initial visit, calculated progression rate, or survival between patients with CAG repeat lengths of 30-33 and patients with CAG repeat lengths <30. These findings support the notion that intermediate-length ATXN2 repeat expansions might be a risk factor in Korean patients with ALS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATXN2; Amyotrophic lateral sclerosis; CAG repeat expansion; Spinocerebellar ataxia type 2

Mesh:

Substances:

Year:  2018        PMID: 29665996     DOI: 10.1016/j.neurobiolaging.2018.03.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  2 in total

1.  Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.

Authors:  Hiroya Naruse; Takashi Matsukawa; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Hiroki Takano; Jun Goto; Tatsushi Toda; Shoji Tsuji
Journal:  Neurogenetics       Date:  2019-03-07       Impact factor: 2.660

2.  The Clinical and Polynucleotide Repeat Expansion Analysis of ATXN2, NOP56, AR and C9orf72 in Patients With ALS From Mainland China.

Authors:  Xiaorong Hou; Wanzhen Li; Pan Liu; Zhen Liu; Yanchun Yuan; Jie Ni; Lu Shen; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.